Use of Topotecan in Patients With Refractory Acute Leukemia
This study has been completed.
First Posted: December 31, 2004
Last Update Posted: September 25, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Information provided by (Responsible Party):
VA Office of Research and Development